Le patient « actionnable » de la médecine personnalisée

Abstract

Personalized Medicine, the new motto of healthcare policy worldwide, is undermined by an ambiguous definition of “personalization”. On the one hand, Personalized Medicine promises that from now on, healthcare systems will focus on patients as whole “persons”. Technoscientific medicine is supposed to become more humane. On the other hand, it labels a deep change in both epistemological and organizational features of technoscientific medicine, due to the development of novel high-throughput molecular analysis technologies. In this paper, I argue that Personalized Medicine is not uppermost a linear move toward a person-centered medicine as opposed to an organ-centered medicine. It is rather an umbrella for global transformations in healthcare systems, leading to new concepts of “person” and responsibility of each individual for his own healthcare status.

Keywords

• actionability
• biomarker
• molecular medicine
• responsability